Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.53 |
| ▸ | NPC1 | O15118 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | APAF1 | O14727 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | HTT | P42858 | 3/20 | 0.53 |
| ▸ | GALK1 | P51570 | 3/20 | 0.53 |
| ▸ | BLM | P54132 | 3/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.53 |
| ▸ | PTBP1 | P26599 | 2/20 | 0.53 |
| ▸ | SMAD3 | P84022 | 2/20 | 0.53 |
| ▸ | THRB | P10828 | 2/20 | 0.53 |
| ▸ | XBP1 | P17861 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | PTPRC | P08575 | 9/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28863139 | 0.81 | NPC1 (0.68) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL13487418 | 0.79 | MEN1 (0.79) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL13487425 | 0.79 | MEN1 (0.79) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL1482692 | 0.77 | MEN1 (0.84) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL7322266 | 0.77 | MEN1 (0.84) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL12553052 | 0.77 | MEN1 (0.83) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL12553042 | 0.77 | MEN1 (0.83) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL12553057 | 0.77 | MEN1 (0.83) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL12553058 | 0.76 | PTPRC (0.67) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL16491649 | 0.76 | PTPRC (0.52) | SMN1; SMN2NPC1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | SMN1; SMN2 3231/4885NPC1 1264/4885RAB9A 3240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.